Treatment of gastroduodenal ulcers with carbonic anhydrase inhibitors.
D000086:Acetazolamide / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000863:Antacids / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001639:Bicarbonates; D002257:Carbonic Anhydrase Inhibitors / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004381:Duodenal Ulcer / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use; D013276:Stomach Ulcer / Q000188:drug therapy*; D013565:Sympatholytics / Q000627:therapeutic use*
D000863:Antacids; D000897:Anti-Ulcer Agents; D001639:Bicarbonates; D002257:Carbonic Anhydrase Inhibitors; D004338:Drug Combinations; D010276:Parasympatholytics; D013565:Sympatholytics; C030084:Ulcosilvanil; D000086:Acetazolamide